24/7
Buzz
Startups
VC
@work
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
DataTech
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Gina Life
Tags search
HOME
24/7
buzz
STARTUPS
VC
Tech@work
Innovation
OPINIONS
EVENTS
ABOUT
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:53
Israel is poised to lead the way in FemTech, but challenges remain in realizing full potential
14:54
Looking good: Israeli startup Sightful takes on Apple in AR glasses race
12:00
“An economic downturn compels entrepreneurs to reevaluate their core business”
10:06
Tel Aviv again drops in global startup ranking
More stories
Buzz
Most popular
Daily
Weekly
1
Why did SentinelOne shares plummet by 35% in a single day?
2
Tel Aviv again drops in global startup ranking
3
Onebeat secures $10 million Series B for AI-enabled supply chain solutions
4
Humanz raises $5 million Series A for AI-based influencer marketing platform
5
The 50 most promising Israeli startups - 2023
More news
Gina Life
3 stories about Gina Life
The FemTech revolution: 7 Israeli companies making headlines in women’s health
21.06.22
|
Noa Gadot
From smart contraceptives to AI powered diagnosis, the global FemTech market size is expected to grow from $28B in 2021 to $33B in 2022 according to The Business Research Company
The femtech duo analyzing discharge to detect female-related diseases
15.11.21
|
Roni Dori
Medical professionals often diagnose diseases based on bodily fluids, but vaginal discharge has long been considered taboo. “Most men don’t even know what it is,” say Dr. Shlomit Yehudai-Reshef and Dr. Inbal Zafir-Lavie, of Gina Life, who are developing a home-testing kit to detect a variety of diseases, from endometriosis to cervical cancer
Microsoft announces second cycle of AI For Good Accelerator Program
09.05.21
|
James Spiro
15 AI companies have been selected across the fields of health, sustainability, and accessibility
Please ensure Javascript is enabled for purposes of
website accessibility